by Maria Zannes | Sep 7, 2023 | Press Releases
SAN ANTONIO, Texas (Sept. 7, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that Maria Zannes, President and CEO, will present a corporate...
by Maria Zannes | Aug 10, 2023 | Press Releases
SAN ANTONIO, Texas (Aug. 14, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...
by Maria Zannes | Jul 12, 2023 | Press Releases
SAN ANTONIO, Texas (July 12, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that the American Medical Association (AMA) has released a...
by Maria Zannes | Jun 15, 2023 | Press Releases
SAN ANTONIO, Texas (June 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for early-stage cancer detection and broad-spectrum cancer therapeutics, will present the poster “Vitamin B12 deprivation does not...
by Maria Zannes | Jun 12, 2023 | Events
bioAffinity Technologies President and CEO Maria Zannes is attending the National Association of Veterans’ Research and Education Foundations’ (NAVREF) quarterly meeting of industry partners in Portland, OR, June 12-13. NAVREF is a non-profit organization dedicated to...
